Large Cap
Medical Instruments & Supplies
Stocks Ranked by
Market Capitalization
| # | Name | Market cap | Price |
Price change % |
|
|---|---|---|---|---|---|
| 1 |
1
Intuitive Surgical
ISRG
$150B
| $150B | $425.76 | 0.42% |
|
| 2 |
2
Becton Dickinson
BDX
$50.6B
| $50.6B | $185.92 | 1.18% |
|
| 3 |
3
ResMed
RMD
$32.7B
| $32.7B | $232.67 | 1.14% |
|
| 4 |
4
Medline Inc
MDLN
$31.8B
| $31.8B | $36.24 | 0.06% |
|
| 5 |
5
Alcon
ALC
$30.9B
| $30.9B | $63.98 | 0.2% |
|
| 6 |
6
West Pharmaceutical
WST
$26.1B
| $26.1B | $371.11 | 1.4% |
|
| 7 |
7
Solventum
SOLV
$14.5B
| $14.5B | $85.33 | 2.25% |
|
| 8 |
8
Baxter International
BAX
$12.7B
| $12.7B | $24.59 | 0.99% |
|
| 9 |
9
Repligen
RGEN
$10.8B
| $10.8B | $170.61 | 1.88% |
|
| 10 |
10
Cooper Companies
COO
$10.5B
| $10.5B | $55.10 | 1.34% |
|
| 11 |
11
Avantor
AVTR
$10.5B
| $10.5B | $15.49 | 1.15% |
|
| 12 |
12
Align Technology
ALGN
$10.1B
| $10.1B | $141.49 | 0.85% |
|
Large Cap Medical Instruments & Supplies Stocks at a Glance
Medical instruments and supplies companies make the consumables and tools of daily care — syringes, catheters, surgical instruments, dental equipment, and eyewear. Recurring, procedure-driven demand makes the group defensive, with razor-and-blade consumable models supporting stable margins.
There are 12 large cap Medical Instruments & Supplies stocks — companies in the Medical Instruments & Supplies industry with a market cap between $10B and $200B — worth a combined $392B.
The largest by market cap are Intuitive Surgical (ISRG) at $150B, Becton Dickinson (BDX) at $50.6B and ResMed (RMD) at $32.7B.
Among institutional investors, Medline Inc (MDLN) drew the most net new fund positions in Q2 2026: 172 funds opened new positions, taking total fund holders up 94 (30%) quarter-over-quarter.
- Combined market cap: $392B across 12 stocks.
- Large Cap: market cap between $10B and $200B.
- Largest constituent: Intuitive Surgical (ISRG), $150B market cap.
- Most net new fund positions in Q2 2026: Medline Inc (MDLN), +94 holders.
Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q2 2026.